상세 보기
Efficacy and safety of lazertinib 240 mg as the clinical dose in patients with EGFR T790M mutant NSCLC: Data from a phase I/II study.
- Lee, Ki Hyeong;
- Ahn, Myung-Ju;
- Han, Ji-Youn;
- Kim, Sang-We;
- Cho, Eun Kyung;
- ... Lee, Gyeong-Won;
- 외 14명
Citations
WEB OF SCIENCE
6- 제목
- Efficacy and safety of lazertinib 240 mg as the clinical dose in patients with EGFR T790M mutant NSCLC: Data from a phase I/II study.
- 저자
- Lee, Ki Hyeong; Ahn, Myung-Ju; Han, Ji-Youn; Kim, Sang-We; Cho, Eun Kyung; Lee, Yun-Gyoo; Kim, Dong-Wan; Kim, Joo-Hang; Lee, Jong-Seok; Lee, Gyeong-Won; Shim, Byoung Yong; Kim, Jin-Soo; Chun, Sang Hoon; Lee, Sung Sook; Min, Young Joo; Shin, Sang Won; Hong, Min Hee; Sun, Jong-Mu; Byun, Hae Mi; Cho, Byoung Chul
- 발행일
- 2020-05-20
- 유형
- Meeting Abstract
- 권
- 38
- 호
- 15
- 언어
- ENG
- 출판사
- American Society of Clinical Oncology
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X